Losartan/Simvastatin

氯沙坦/辛伐他汀

Report date: 2025/04/21 20:01:10

Base Information

Drug NameLosartan/Simvastatin
Drug Alias Name氯沙坦+辛伐他汀Losartan Potassium/Simvastatin氯沙坦jia/辛伐他汀Losartan+SimvastatinSimvastatin+Losartan +[8] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsEmotional RegulationHyperlipidemiasHypertension +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsYes Losartan PotassiumSimvastatin
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanall
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalUniversity Of Oxford
Inactive CompaniesHanall
Active IndicationsEmotional RegulationJoint Diseases
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A